Subscribe

Michael R. Page, PharmD, RPh

Articles by Michael R. Page, PharmD, RPh

Trial Initiated to Measure Efficacy of T-Cell Therapy in Secondary Progressive MS

ByMichael R. Page, PharmD, RPh

June 13th 2014

Opexa Therapeutics is initiating a phase IIb trial of a novel therapy that targets T-cells in patients with secondary progressive multiple sclerosis.

Latest Updated Articles

Trial Initiated to Measure Efficacy of T-Cell Therapy in Secondary Progressive MS
Published: June 13th 2014 | Updated:

Trending on CGTlive®

PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data

Quarter Century Update: The Impact of Artificial Intelligence

Data Roundup: October 2025 Features Updates from ESMO, ESGCT, and More

© 2025 MJH Life Sciences^®

All rights reserved.